Patients with esophageal cancer, especially upper esophageal cancer, are prone to supraclavicular lymph node metastasis, while middle and lower esophageal cancer can also have supraclavicular lymph node metastasis. In the past, it was listed as one of the contraindications of esophageal cancer surgery. In the past two decades, with the improvement of surgical methods and the development of radiotherapy technology, especially with the research of evidence-based medicine in the past five years, the survival rate of esophageal cancer patients after surgery has been greatly improved, and there are new views on the surgical treatment of esophageal cancer patients with supraclavicular lymph node metastasis. Supraclavicular lymph node metastasis is not necessarily a contraindication to surgery. Clinical studies have found that: a. When the primary esophageal cancer lesion can be resected and supraclavicular lymph nodes can be resected, primary esophageal cancer resection + cervical lymph node dissection can be performed at the same time. According to the patient’s condition, postoperative radiotherapy and chemotherapy can be used. Secondly, if the primary esophageal cancer lesion can be resected and supraclavicular lymph nodes are suspicious for resection, radiotherapy can be performed first with radiotherapy, and then primary esophageal cancer resection + cervical lymph node dissection can be performed. Postoperatively, it is supplemented with radiotherapy and chemotherapy. Through the above standardized treatment, good results can be achieved. Third, if supraclavicular lymph nodes are unresectable, surgical treatment is not recommended.